Publications

Lau C, Mole ML, Copeland FM, Rogers JM, Kavlock RJ, Shuey DL, Cameron AM, Ellis DH, Logsdon TR, Merriman J, Setzer RW. 2001. Toward a biologically-based dose-response model for the developmental toxicity of 5-fluorouracil in the rat: Acquisition of experimental data. Toxicol Sci 59(1):37–48; doi: 10.1093/toxsci/59.1.37.

Setzer RW, Lau C, Mole ML, Copeland FM, Rogers JM, Kavlock RJ. 2001. Toward a biologically-based dose-response model for the developmental toxicity of 5-fluorouracil in the rat: A mathematical construct. Toxicol Sci 59(1):49–58; doi: 10.1093/toxsci/59.1.49.

Leazer TM, Rogers JM. 2001. Role of the acute phase response and tissue necrosis factor alpha in the developmental toxicity of lipopolysaccharide in the CD-1 mouse. Reprod Toxicol 16(2):173–179; doi: 10.1016/S0890-6238(02)00011-4. PMID: 11955948.

Kolanz ME, Madl AK, Kelsh MA, Kent MS, Kalmes RM, Paustenbach DJ. 2001. A comparison and critique of historical and current exposure assessment methods for beryllium: Implications for evaluating risk of chronic beryllium disease. Appl Occup Environ Hyg 16(5):593–614; doi: 10.1080/10473220119613. PMID: 11370938.

Deubner D, Kelsh MA, Shum M, Maier L, Kent MS, Lau E. 2001. Beryllium sensitization, chronic beryllium disease, and exposures at a beryllium mining and extraction facility. Appl Occup Environ Hyg 16(5):579–592; doi: 10.1080/104732201750169697. PMID: 11370937.

Mandel J, Kelsh MA. 2001. A review of the epidemiology of trichloroethylene and kidney cancer. Hum Ecol Risk Assess 7(4):727–735; doi: 10.1080/20018091094600.

Goodman M, Kelsh MA, Ebi KL, Ianuzzi J, Langholz B. 2001. Evaluation of potential confounders in planning a study of occupational magnetic field exposure and female breast cancer. Epidemiol 13:50–58.

Yager JW, Kelsh MA, Zhao K, Mrad RJ. 2001. Development of an occupational illness and injury surveillance database for the electric energy sector. Appl Occup Environ Hyg 16(2):291–294; doi: 10.1080/10473220121231. PMID: 11217725.

Hofelt CS, Honeycutt M, McCoy JT, Haws LC. 2001. Development of a metabolism factor for polycyclic aromatic hydrocarbons for use in multipathway risk assessments for hazardous waste combustion facilities. Reg Toxicol Pharmacol 33(1):60-65; doi: 10.1006/rtph.2000.1438.

Albrecht B, Collins ND, Burniston MT, Nisbet JW, Ratner L, Green PL, Lairmore MD. 2000. Human T-lymphotropic virus type 1 open reading frame I p12I is required for efficient viral infectivity in primary lymphocytes. J Virol 74(21):9828–9835; doi: 10.1128/jvi.74.21.9828-9835.2000. PMID: 11024109.

Greenland S, Sheppard AR, Kaune WT, Poole C, Kelsh MA. 2000. A pooled analysis of magnetic fields, wire codes and childhood leukemia. Epidemiol 227(2):294–306; doi: 10.1097/00001648-200011000-00003. PMID: 11055621.

Smith DM, Grasty RC, Theodosiou NA, Tabin CJ, Nascone-Yoder NM. 2000. Evolutionary relationships between the amphibian, avian, and mammalian stomachs. Evolut Develop 2(6):348-59; doi: 10.1046/j.1525-142x.2000.00076.x. PMID: 11256379.

Shipp AM, Gentry PR, Lawrence G, Van Landingham C, Covington T, Clewell HJ, Gribben K, Crump K. 2000. Determination of a site-specific reference dose for methylmercury for fish-eating populations. Toxicol Ind Health 16(9-10):335–438.

Mcnamara JF, Lombardo H, Pillai SK, Jensen I, Albericio F, Kates SK. 2000. An efficient solid-phase strategy for the construction of chemokines. J Pept Sci 6(10):512–518; doi: 10.1002/1099-1387(200010)6:10<512::AID-PSC269>3.0.CO;2-A.

Newbound GC, O’Rourke JP, Collins ND, Andrews JM, DeWille J, Lairmore MD. 2000. Repression of tax-mediated human T-lymphotropic virus type 1 transcription by inducible cAMP early repressor (ICER) protein in peripheral blood mononuclear cells. J Med Virol 62(2):286–292; doi: 10.1002/1096-9071(200010)62:2<286::AID-JMV22>3.0.CO;2-Y.  PMID: 11002260.

Andersen ME, Sarangapani R, Gentry PR, Clewell HJ, Covington TR, Frederick CB. 2000. Application of a hybrid CFD-PBPK nasal dosimetry model in an inhalation risk assessment: An example with acrylic acid. Toxicol Sci 57(2):312–325; doi: 10.1093/toxsci/57.2.312.

Thompson CM, Capdevila JH, Strobel HW. 2000. Recombinant P450 2D18 metabolism of dopamine and arachidonic acid. J Pharmacol Exper Ther 294(3):1120–1130; doi: 10.1016/S0022-3565(24)39180-3. PMID: 10945868.

Kelsh MA, Kheifets LI, Smith RW. 2000. The impact of work environment, utility and sampling design on occupational exposure summaries. AIHA J 61(2):174–182; doi: 10.1080/15298660008984526.

Jankowski-Hennig MA, Clegg MS, Daston GP, Rogers JM, Keen CL. 2000. Zinc-deficient rat embryos have increased caspase 3-like activity and apoptosis. Biochem Biophys Res Commun 271(1):250–256; doi: 10.1006/bbrc.2000.2608.

Lau C, Anderson ME, Crawford-Brown DJ, Kavlock RJ, Kimmel CA, Knudsen TB, Muneoka K, Rogers JM, Setzer RW, Smith G, Tyl R. 2000. Evaluation of biologically based dose-response modeling for developmental toxicity: A workshop report. Regul Toxicol Pharmacol 31(2):190–199; 10.1006/rtph.1999.1360.